The prefilled syringe which opens the door for self-administration in the U.S., is expected to be a key driver of this growth in 2025 for both MG and CIDP. It is incredible to see the strong early ...

College of Chemical and Biological Engineering, Zhejiang University, Hangzhou, Zhejiang 310027, China ZJU-Hangzhou Global Scientific and Technological Innovation Center, Zhejiang University, Hangzhou ...

They instead recommend alternative methods, such as basal-bolus insulin. However, some healthcare professionals may still temporarily use sliding scale insulin therapy for people with noncritical ...